Skip to Content

Core B: Biostatistics Core

Publications

Bold indicates an investigator affiliated with the MD Anderson Ovarian Cancer SPORE or an Ovarian Cancer SPORE at another institution.

  1. Baggerly KA, Edmonson SR, Morris JS, Coombes KR. High-resolution serum proteomic patterns for ovarian cancer detection. Endocr Relat Cancer. 2004 Dec;11(4):583-4; author reply 585-7. No abstract available. PMID: 15613439.
    Full Text
  2. Baggerly KA, Morris JS, Coombes KR. Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experiments. Bioinformatics 20(5):777-85, 3/2004. PMID: 14751995.
    Abstract
  3. Baggerly KA, Morris JS, Edmonson SR, Coombes KR. Signal in noise: evaluating reported reproducibility of serum proteomic tests for ovarian cancer. J Natl Cancer Inst. 2005 Feb 16;97(4):307-9. PMID: 15713966.
    Abstract
  4. Hu J, Coombes KR, Morris JS, Baggerly KA. The importance of experimental design in proteomic mass spectrometry experiments: some cautionary tales. Brief Funct Genomic Proteomic. 2005 Feb;3(4):322-31. Review. PMID: 15814023.
    Abstract
  5. Coombes KR, Tsavachidis S, Morris JS, Baggerly KA, Hung MC, Kuerer HM. Improved peak detection and quantification of mass spectrometry data acquired from surface-enhanced laser desorption and ionization by denoising spectra with the undecimated discrete wavelet transform. Proteomics, 2005. 5(16): p. 4107-17. PMID: 16254928.
    Abstract
  6. Hu J, He X, Baggerly KA, Coombes KR, Hennessy BT, Mills GB. Nonparametric quantification of protein lysate arrays. Bioinformatics 23:1986-94, 2007. PMID: 17599930.
    Abstract
  7. Coombes KR, Wang J, Baggerly KA. Microarrays: retracing steps. Nat Med 13(11):1276-7; author reply 1277-8, 11/2007. PMID: 17987014.
    Abstract
  8. Baggerly KA, Coombes KR, Neeley ES. Run batch effects potentially compromise the usefulness of genomic signatures for ovarian cancer. J Clin Oncol. 2008 Mar 1;26(7):1186-7. No abstract available. PMID: 18309960.
    Full Text
  9. Baggerly KA, Coombes KR. Deriving chemosensitivity from cell lines: forensic bioinformatics and reproducible research in high-throughput biology. Ann App Stat, In Press. [no PMID]
  10. Moore RG, Jabre-Raughley M, Brown AK, Robison KM, Miller MC, Allard J, Nilsson O, Kurman RJ, Bast RC Jr, Skates SJ. Comparison of a novel multiple marker assay versus the risk of malignancy index for the prediction of epithelial ovarian cancer in patients with a pelvic mass. Gynecol Oncol, In press. [no PMID]

© 2013 The University of Texas MD Anderson Cancer Center